Help a Mother Protect Her Autism Discovery and Her Daughter's Story
The Issue
What did Kimberly Kitzerow discover?
Kimberly Kitzerow developed Kitzerow's Autism and the Comorbidities Cascade, a scientific hypothesis about how autism arises and why co-occurring conditions so often appear with it.
The Cascade proposes that autism and comorbid traits occur and vary as genetic and epigenetic factors chronically activate the stress response system during critical periods of development and throughout life. Through the BH4 Shunt, the body reprioritizes its regulatory network, functionally shifting biochemical pathway activity and reallocating resources to the stress response over typical development and function. It proposes that as the nervous system develops and functions atypically during critical time periods of development, autism traits may occur. Because the body's systems are interconnected, the same reallocation has a systemic impact that drives comorbid traits. Both cluster based on the type, timing, duration, and strength of the impact.
Kitzerows Autism and the Comorbidities Cascade is a hypothesis for understanding autism, not a treatment. It is still being researched, and its validation depends on continued testing and convergent evidence.
Who is Kimberly Kitzerow?
Kimberly Kitzerow is an educator specializing in data synthesis, an author, and the founder of Kimberly's Educational Resources LLC. She writes books and shares information to help others understand autism. After helping her nonverbal autistic daughter learn to speak, she developed two systems that synthesize published research to improve how autism is understood and accommodated. NeuroToggle® brings together what is known about how the brain learns, matching teaching strategies to neuroplasticity to support neurodiverse learners. BioToggle® brings together what is known about genetic regulation, explaining how it drives physiological plasticity and giving families and educators a foundation for understanding the biology behind autism and its co-occurring conditions.
How did Kitzerow help her daughter learn to speak?
Kitzerow used neuroplasticity-based early intervention, an educational approach built on how the brain learns. She shares the full approach in her parent guide, You Are Not Alone, with an overview on From Silence to Speech.
How did the discovery happen?
As Kimberly compiled the research behind NeuroToggle® and BioToggle®, she noticed a pattern connecting autism and its common co-occurring conditions through the BH4 pathway. She hypothesized that genetic and epigenetic factors could produce persistent changes in the stress response. Those changes would shift activity in BH4-dependent pathways and influence how the nervous system develops and functions.
To test it, Kimberly built a species-level biochemical network from gene-coded protein data in UniProt. She then compared published autism biomarkers and genetic findings against it to see whether the BH4 pathway is dysregulated in autistic individuals. The differences fell on redox-sensitive regulation of BH4-dependent and precursor pathways. Using existing data this way is common in bioinformatics.
Kitzerow’s daughter was the inspiration. NeuroToggle® and BioToggle® organize what is already known. The Cascade, which came out of that testing, is Kimberly's original contribution.
How was the Cascade developed?
It began as a loosely formed concept and was refined over several years across eight papers:
- The Origin: Kimberly helped her nonverbal autistic daughter speak through a neuroplasticity-informed early intervention approach.
- Initial literature review and BH4 hypothesis (January 2024)
Kimberly synthesized published research on autism, co-occurring conditions such as nonverbality, genetics, and biochemistry. She identified recurring relationships involving the BH4 pathway and proposed it as the connection between autism and its comorbidities.
Paper: Autism & the Comorbidities Along the BH4 Pathway - Biochemical network variables (August 2024)
She established the genomic, proteomic, and cellular regulatory variables needed to build a biochemical network and analyze the hypothesis against it.
Paper: Genomic and Proteomic Regulation in Cellular Homeostasis: From Molecular Mechanisms to Clinical Implication - Comparative analysis and the BH4 Shunt (August 2024)
She compared published autism findings against the network and developed the BH4 Shunt, a proposed redox-sensitive stress response mechanism connecting nervous system differences and systemic comorbidities.
Paper: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities - Cascade observations (April 2025)
Three papers expanded the analysis. They examined how systemic load may change kinetic behavior and enzyme thresholds, including the effects of oversupplementation. They also organized regulatory and temporal system domains to show how biological regulation and timing shape physiological responses.
Papers: The Shift in Kinetic Laws Under Systemic Load, Beyond Saturation: Enzymatic Kinetic Thresholds, Systemic Load, and the Impact of Oversupplementation, and BioToggle and BioDial Categorical Delineation - Integrated systems-level model (July 2025)
Through comparative analysis Kitzerow identified the nodes and edges of the biochemical network that were different in autism biomarker collections and genetic variants identifying convergence around redox-sensitive proteins and their metabolites. She then documented and published the biochemical cascade impacted on ResearchGate.
Paper: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory - Research guide (November 2026)
She consolidated the hypothesis, methods, comparative findings, supporting evidence, proposed biomarkers, and testable predictions into one guide for researchers.
Paper: Kitzerow's Autism and the Comorbidities Cascade: A Research Guide to the Hypothesis, Methods, and Predictions
How do validation and citation work?
If the Cascade is accurate, independent studies should arrive at related findings. Several published since 2025 already overlap with its mechanisms. Kimberly tracks them in her Recent Tests of the Cascade page.
As with any discovery, citation keeps new work connected to where an idea began. For the Cascade, that origin is a mother and daughter, and a public record that starts with the social media release in May 2023, memoir September 2023, and first ResearchGate paper in January 2024.
To cite the original hypothesis: Kitzerow, K. (2024). Autism & the comorbidities along the BH4 pathway. ResearchGate. https://doi.org/10.13140/RG.2.2.23124.37761/1
How can you get involved?
Kimberly welcomes researchers, clinicians, and educators who want to test, challenge, or build on the Cascade. The research guide lays out its predictions in one place to make that work easy to start. Reach her through kimberlyedu.org.
You can also sign and share this petition and pass the research guide along to anyone studying autism.
630
The Issue
What did Kimberly Kitzerow discover?
Kimberly Kitzerow developed Kitzerow's Autism and the Comorbidities Cascade, a scientific hypothesis about how autism arises and why co-occurring conditions so often appear with it.
The Cascade proposes that autism and comorbid traits occur and vary as genetic and epigenetic factors chronically activate the stress response system during critical periods of development and throughout life. Through the BH4 Shunt, the body reprioritizes its regulatory network, functionally shifting biochemical pathway activity and reallocating resources to the stress response over typical development and function. It proposes that as the nervous system develops and functions atypically during critical time periods of development, autism traits may occur. Because the body's systems are interconnected, the same reallocation has a systemic impact that drives comorbid traits. Both cluster based on the type, timing, duration, and strength of the impact.
Kitzerows Autism and the Comorbidities Cascade is a hypothesis for understanding autism, not a treatment. It is still being researched, and its validation depends on continued testing and convergent evidence.
Who is Kimberly Kitzerow?
Kimberly Kitzerow is an educator specializing in data synthesis, an author, and the founder of Kimberly's Educational Resources LLC. She writes books and shares information to help others understand autism. After helping her nonverbal autistic daughter learn to speak, she developed two systems that synthesize published research to improve how autism is understood and accommodated. NeuroToggle® brings together what is known about how the brain learns, matching teaching strategies to neuroplasticity to support neurodiverse learners. BioToggle® brings together what is known about genetic regulation, explaining how it drives physiological plasticity and giving families and educators a foundation for understanding the biology behind autism and its co-occurring conditions.
How did Kitzerow help her daughter learn to speak?
Kitzerow used neuroplasticity-based early intervention, an educational approach built on how the brain learns. She shares the full approach in her parent guide, You Are Not Alone, with an overview on From Silence to Speech.
How did the discovery happen?
As Kimberly compiled the research behind NeuroToggle® and BioToggle®, she noticed a pattern connecting autism and its common co-occurring conditions through the BH4 pathway. She hypothesized that genetic and epigenetic factors could produce persistent changes in the stress response. Those changes would shift activity in BH4-dependent pathways and influence how the nervous system develops and functions.
To test it, Kimberly built a species-level biochemical network from gene-coded protein data in UniProt. She then compared published autism biomarkers and genetic findings against it to see whether the BH4 pathway is dysregulated in autistic individuals. The differences fell on redox-sensitive regulation of BH4-dependent and precursor pathways. Using existing data this way is common in bioinformatics.
Kitzerow’s daughter was the inspiration. NeuroToggle® and BioToggle® organize what is already known. The Cascade, which came out of that testing, is Kimberly's original contribution.
How was the Cascade developed?
It began as a loosely formed concept and was refined over several years across eight papers:
- The Origin: Kimberly helped her nonverbal autistic daughter speak through a neuroplasticity-informed early intervention approach.
- Initial literature review and BH4 hypothesis (January 2024)
Kimberly synthesized published research on autism, co-occurring conditions such as nonverbality, genetics, and biochemistry. She identified recurring relationships involving the BH4 pathway and proposed it as the connection between autism and its comorbidities.
Paper: Autism & the Comorbidities Along the BH4 Pathway - Biochemical network variables (August 2024)
She established the genomic, proteomic, and cellular regulatory variables needed to build a biochemical network and analyze the hypothesis against it.
Paper: Genomic and Proteomic Regulation in Cellular Homeostasis: From Molecular Mechanisms to Clinical Implication - Comparative analysis and the BH4 Shunt (August 2024)
She compared published autism findings against the network and developed the BH4 Shunt, a proposed redox-sensitive stress response mechanism connecting nervous system differences and systemic comorbidities.
Paper: The BH4 Pathway as an Allostatic Mechanism in the Pathology of Autism and Systemic Comorbidities - Cascade observations (April 2025)
Three papers expanded the analysis. They examined how systemic load may change kinetic behavior and enzyme thresholds, including the effects of oversupplementation. They also organized regulatory and temporal system domains to show how biological regulation and timing shape physiological responses.
Papers: The Shift in Kinetic Laws Under Systemic Load, Beyond Saturation: Enzymatic Kinetic Thresholds, Systemic Load, and the Impact of Oversupplementation, and BioToggle and BioDial Categorical Delineation - Integrated systems-level model (July 2025)
Through comparative analysis Kitzerow identified the nodes and edges of the biochemical network that were different in autism biomarker collections and genetic variants identifying convergence around redox-sensitive proteins and their metabolites. She then documented and published the biochemical cascade impacted on ResearchGate.
Paper: Neurodivergent Biochemistry and the Autism and the Comorbidities Theory - Research guide (November 2026)
She consolidated the hypothesis, methods, comparative findings, supporting evidence, proposed biomarkers, and testable predictions into one guide for researchers.
Paper: Kitzerow's Autism and the Comorbidities Cascade: A Research Guide to the Hypothesis, Methods, and Predictions
How do validation and citation work?
If the Cascade is accurate, independent studies should arrive at related findings. Several published since 2025 already overlap with its mechanisms. Kimberly tracks them in her Recent Tests of the Cascade page.
As with any discovery, citation keeps new work connected to where an idea began. For the Cascade, that origin is a mother and daughter, and a public record that starts with the social media release in May 2023, memoir September 2023, and first ResearchGate paper in January 2024.
To cite the original hypothesis: Kitzerow, K. (2024). Autism & the comorbidities along the BH4 pathway. ResearchGate. https://doi.org/10.13140/RG.2.2.23124.37761/1
How can you get involved?
Kimberly welcomes researchers, clinicians, and educators who want to test, challenge, or build on the Cascade. The research guide lays out its predictions in one place to make that work easy to start. Reach her through kimberlyedu.org.
You can also sign and share this petition and pass the research guide along to anyone studying autism.
The Decision Makers
Supporter Voices
Petition Updates
Share this petition
Petition created on May 13, 2026